Targeting the Immunoglobulin IGSF9 Enhances Antitumor T-cell Activity and Sensitivity to Anti-PD-1 Immunotherapy.
Cancer Res
; 83(20): 3385-3399, 2023 Oct 13.
Article
in En
| MEDLINE
| ID: mdl-37506192
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Diagnostic_studies
Language:
En
Journal:
Cancer Res
Year:
2023
Document type:
Article
Country of publication:
Estados Unidos